SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-17-040412
Filing Date
2017-02-13
Accepted
2017-02-13 16:08:03
Documents
3
Group Members
KEVIN P. STARRMARK LEVINROBERT I. TEPPERTHIRD ROCK VENTURES GP II, L.P.THIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES III, L.P.TRV GP II, LLCTRV GP III, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 d347369dsc13ga.htm SC 13G/A 164610
2 EX-24 d347369dex24.htm EX-24 3666
3 EX-99.1 d347369dex991.htm EX-99.1 13149
  Complete submission text file 0001193125-17-040412.txt   183203
Mailing Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures II, L.P. (Filed by) CIK: 0001488495 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Subject) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89169 | Film No.: 17599107
SIC: 2834 Pharmaceutical Preparations